Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/21/2009CN101559115A Application of traditional Chinese medicine composition in preparing medicament for curing senile dementia
10/21/2009CN101559092A Application of eucommia ulmoides extracts
10/21/2009CN101559085A Extracting method for improving content of bilobalide in folium ginkgo extract
10/21/2009CN101559054A Chemical compound medicament for curing alcohol dependence
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/21/2009CN101558879A Teabag containing paeoniifolia for calming and tranquilizing mind and manufacturing method thereof
10/21/2009CN101558867A New antialcoholic food and production method thereof
10/21/2009CN100551924C 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/21/2009CN100551915C 8-chloro-2,3-benzodiazepine derivatives
10/21/2009CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551430C Brain nourishing and eyesight improving tea
10/21/2009CN100551429C Medicament for nourishing liver and kidney, strengthening brain and developing intelligence and its preparation method
10/21/2009CN100551424C Chinese traditional combination having anti-alcohol function
10/21/2009CN100551410C Antidepressive medicine and its preparation method
10/21/2009CN100551393C Honey polygala root and its preparation method
10/21/2009CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation
10/21/2009CN100551373C Buspirone hydrochloride slow/controlled release micro pill
10/21/2009CN100551371C Zirasitone mesylate soluble medicinal preparation
10/21/2009CN100551356C Membrane production technology of spirit-quieting brain-replenishing liquid and its product
10/21/2009CN100551308C Chinese medicine pillow
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605260 Process for producing imide compound
10/20/2009US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009US7605173 Pharmaceutical liquid composition containing pyridone derivative
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605163 Benzoyl-piperazine derivatives
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7604993 Generation of neuronal cells for use in the treatment of nervous system disorders; preparing nutrient broth contain nerve growth factor, inoculating with cells, producing neuronal precursor cells or glial precursor cells
10/20/2009CA2527093C 3-fluoro-piperidines as nmda/nr2b antagonists
10/20/2009CA2492854C Sustained-release tablet composition of pramipexole
10/20/2009CA2469821C Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/20/2009CA2446712C System for osmotic delivery of pharmaceutically active agents
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2379294C Process for preparing dibenzothiazepine derivatives
10/20/2009CA2368843C Neurotrophic substituted pyrimidines
10/20/2009CA2364662C 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2009CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/20/2009CA2168937C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
10/15/2009WO2009126931A2 Combination therapy for bipolar disorder
10/15/2009WO2009126778A2 Compositions and methods for treating neurodegenerative diseases
10/15/2009WO2009126675A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009WO2009126530A2 Cgrp receptor antagonists
10/15/2009WO2009126350A2 Methods and compositions for targeting polyubiquitin
10/15/2009WO2009126333A1 Oligomer-aryloxy-substituted propanamine conjugates
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125196A1 Neural circuits and stereotactic apparatus
10/15/2009WO2009125140A2 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/15/2009WO2009124996A1 Anhydrous crystal form of orvepitant maleate
10/15/2009WO2009124956A1 Pyridine derivatives used to treat orexin related disorders
10/15/2009WO2009124882A1 Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124746A1 Substituted sulfonamide derivatives
10/15/2009WO2009103150A4 Method for treating migraine headaches
10/15/2009WO2009099563A3 Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009WO2009091542A9 Antibodies to bufadienolides prevent inhbition of na/katpase and prolong survival in shock
10/15/2009WO2009089284A3 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist
10/15/2009WO2009087667A3 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions
10/15/2009WO2009065920A3 Compounds
10/15/2009WO2009059047A3 Tricyclic compounds and methods for using the same
10/15/2009WO2009056811A3 Tetrahydrobenzothiazole derivatives with dopamine receptor activity
10/15/2009WO2009052454A3 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
10/15/2009WO2009050554A3 Pyrazolo [4, 3d] pyrimidine derivatives for use in promoting functional recovery
10/15/2009WO2009047779A3 Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009015000A8 Pyrazole urea derivatives used as kinase inhibitors
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258951 Use of vanillyl alcohol for the treatment of Parkinson's disease
10/15/2009US20090258948 Pharmaceutical salts
10/15/2009US20090258947 Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258934 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
10/15/2009US20090258925 Natural antisense and non-coding rna transcripts as drug targets
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258905 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/15/2009US20090258903 Aminoethane Sulfonamide Orexin Receptor Antagonists
10/15/2009US20090258902 Biphenyl-pyrazolecarboxamide compounds
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258898 Amides of acetic and propionic acids
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258883 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds
10/15/2009US20090258880 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in Pharmaceutical Compositions
10/15/2009US20090258871 Aza-Substituted Spiro Derivatives
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258866 CGRP Receptor Antagonists
10/15/2009US20090258847 Cholanic Acid Amides
10/15/2009US20090258844 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
10/15/2009US20090258824 Amyloid beta receptor and uses thereof
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258814 Method for treating a synucleinopathy
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 1833